Specialty-specific guidance
The development of guidance is a key function of the College to support good practice and service provision. Guidance documents that have been developed specifically for a particular specialty are listed below.
If you cannot see a College document, it might be archived or withdrawn or listed under cross-specialty guidance.
Confidential documents or those still in the consultation stage are on the Consultation listings page and require members to log in.
The College is currently undertaking a large programme to update the autopsy scenarios originally published as guidance in 2005. The newly published/updated scenarios are listed on the Autopsy guidelines page.
Histopathology/cellular pathology
On 28 October 2020, NICE published a diagnostics guidance document DG42: Testing strategies for Lynch syndrome in people with endometrial cancer, which states testing for Lynch syndrome should be offered when a person is diagnosed with endometrial cancer. This puts cellular pathology departments in the primary position of response when a diagnosis of endometrial cancer is made. Robust arrangements for communications with treating clinicians, genomic laboratory hubs and clinical geneticists are required.
The British Association of Gynaecological Pathologists, in association with the British Gynaecological Cancer Society and the Royal College of Pathologists, has produced a flowchart of the proposed pathway, followed by a synopsis of the terminology for reports.
Medical microbiology and medical virology
Prepared by the British Infection Association Clinical Services Committee in conjunction with the Royal College of Physicians Infectious Diseases Joint Specialist Committee and the Royal College of Pathologists' Specialty Advisory Committee.
Neuropathology
This document was prepared by Dr M Hofer on behalf of the British Neuropathological Society and approved for cobadging by RCPath in April 2022.